Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL CURRENT ASSETS
Total Current Assets REGN - Regeneron Pharmaceuticals, Inc.
18.7 B
LAST VALUE
-8.04%
2 YEAR CAGR
12.06%
5 YEAR CAGR
22.23%
10 YEAR CAGR